The Cost-effectiveness of Treating Diabetic Lower Extremity Ulcers with Becaplermin (Regranex): A Core Model with an Application Using Swedish Cost Data-Reference-Cited by-同舟云学术

The Cost-effectiveness of Treating Diabetic Lower Extremity Ulcers with Becaplermin (Regranex): A Core Model with an Application Using Swedish Cost Data

Published:2000-11 Issue: Volume:3 Page:S39-S46
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Persson Ulf,Willis Michael,Ödegaard Knut,Apelqvist Jan

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference17 articles.

1. Diabetes—a Study in Health Economics. IHE report no. 7;Jönsson,1981

2. Economic Aspects of Diabetic Neuropathy and Related Diabetic Complications;Johnson,1997

3. International Consensus on the Diabetic Foot. Third International Symposium of the Diabetic Foot;International Working Group on the Diabetic Foot,1999

4. The economic cost of non-insulin dependent diabetes mellitus;Huse;JAMA,1989

5. The burden of diabetic foot ulcers;Reiber;A J Surg,1998

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Diabetic Wound-Healing Outcomes With Topical Growth Factor Therapies;The Journal of Clinical Endocrinology & Metabolism;2024-03-13

2. Stepping up foot care: assessment over foot care knowledge and behavior among individuals with diabetes of risk levels;International Journal of Diabetes in Developing Countries;2023-10-28

3. Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective;JAMA Network Open;2023-01-12

4. Economic evaluations considering costs and outcomes of diabetic foot ulcer infections: A systematic review;PLOS ONE;2020-04-30

5. Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications;Expert Review of Pharmacoeconomics & Outcomes Research;2017-03-04